I-Med Pharma USA Partners With DryEye Rescue to Distribute Its Innovative Dry Eye Product Portfolio in the United States
February 03, 2022 11:00 ET
|
I-MED Pharma
MONTREAL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- With the recent launch of its line of dry eye diagnostics, management, and treatment solutions into the United States, I-MED Pharma USA has partnered with...
NTC and I-MED Pharma form strategic partnership to bring the leading HA-based dry eye ointment to the United States market
December 15, 2021 07:00 ET
|
I-MED Pharma
MONTREAL, Dec. 15, 2021 (GLOBE NEWSWIRE) -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and...
I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
November 09, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business...
I-MED Pharma USA Announces Brent Jones as Chief Commercial Officer
November 08, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 08, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer...
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.
November 05, 2021 11:00 ET
|
I-MED Pharma
MONTREAL, Nov. 05, 2021 (GLOBE NEWSWIRE) -- I-MED Pharma USA is bringing the world’s most innovative dry eye product portfolio to the U.S. market. Their uniquely formulated line of ocular surface...
Clinical Trials Elate Dry Eye Syndrome Market – Straits Research
September 20, 2021 10:00 ET
|
Straits Research
New York, United States, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The dry eye syndrome market is expected to grow at a compound annual growth rate (CAGR) of 6.4% in the forecast period from 2020 to 2029. ...
Dry Eye Products Market Growth Sturdy at 4.8% CAGR to Outstrip $9,141.01 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
May 07, 2021 09:30 ET
|
The Insight Partners
Pune, India., May 07, 2021 (GLOBE NEWSWIRE) -- Dry Eye Products Market: Key InsightsAccording to our new research study on “Dry Eye Products Market to 2027 – Global Analysis and Forecast – by...
I-MED Pharma launches tearcheck® in Canada - A new standard in dry eye analysis
November 10, 2020 10:20 ET
|
I-MED Pharma
MONTREAL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announces the launch of tearcheck®, a new Health Canada approved...
I-MED Pharma to Launch Its Most Advanced Artificial Tear to Date With I-DROP® MGD
February 03, 2020 14:11 ET
|
I-MED Pharma
MONTREAL, Feb. 03, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the company has plans to launch its newest,...
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
June 17, 2019 11:05 ET
|
I-MED Pharma
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal...